OTC Markets OTCQB USD

BetterLife Pharma Inc. (BETRF)

0.0870 +0.0010 (+1.16%)
At close: June 7 at 12:44 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
1/31/2020
Operating Expense
3,209.8890
3,209.8890
9,257.4410
9,969.6190
7,954.4170
--
Operating Income
-3,209.8890
-3,209.8890
-9,257.4410
-9,969.6190
-7,954.4170
--
Net Non Operating Interest Income Expense
-84.9470
-84.9470
-91.0950
-1,282.8670
-222.0350
--
Other Income Expense
396.3260
396.3260
-24.2360
-740.0220
-28,174.3380
--
Pretax Income
-2,898.5100
-2,898.5100
-9,372.7720
-11,992.5080
-36,350.7900
--
Tax Provision
--
--
--
166.6660
--
--
Net Income Common Stockholders
-2,889.0320
-2,889.0320
-9,016.2010
-12,159.1740
-36,350.7900
--
Diluted NI Available to Com Stockholders
-2,889.0320
-2,889.0320
-9,016.2010
-12,159.1740
-36,350.7900
--
Basic EPS
-0.03
-0.03
-0.10
-0.16
-1.34
--
Diluted EPS
-0.03
-0.03
-0.10
-0.16
-1.34
--
Basic Average Shares
109,285.9570
109,285.9570
86,560.7600
75,469.5310
27,027.0280
--
Diluted Average Shares
109,285.9570
109,285.9570
86,560.7600
75,469.5310
27,027.0280
--
Total Operating Income as Reported
-3,240.2410
-3,240.2410
-9,460.6530
-10,207.8250
-7,915.3670
--
Rent Expense Supplemental
--
--
--
--
479.1640
347.4450
Total Expenses
3,209.8890
3,209.8890
9,257.4410
9,969.6190
7,954.4170
--
Net Income from Continuing & Discontinued Operation
-2,889.0320
-2,889.0320
-9,016.2010
-12,159.1740
-36,350.7900
--
Normalized Income
-3,320.0450
-3,320.0450
-8,878.8560
-11,847.4386
-8,216.8100
--
Interest Income
--
--
--
--
0.2650
4.4790
Interest Expense
50.8970
50.8970
67.1780
58.3450
40.1000
--
Net Interest Income
-84.9470
-84.9470
-91.0950
-1,282.8670
-222.0350
--
EBIT
-2,847.6130
-2,847.6130
-9,305.5940
-11,934.1630
-36,310.6900
--
EBITDA
-2,847.6130
-2,847.6130
-9,287.1590
-11,915.7270
-35,967.8770
--
Reconciled Depreciation
--
--
18.4350
18.4360
342.8130
--
Net Income from Continuing Operation Net Minority Interest
-2,889.0320
-2,889.0320
-9,016.2010
-12,159.1740
-36,350.7900
--
Total Unusual Items Excluding Goodwill
431.0130
431.0130
-137.3450
-422.4630
-28,133.9800
--
Total Unusual Items
431.0130
431.0130
-137.3450
-422.4630
-28,133.9800
--
Normalized EBITDA
-3,278.6260
-3,278.6260
-9,149.8140
-11,493.2640
-7,833.8970
--
Tax Rate for Calcs
--
--
--
0.0003
--
--
Tax Effect of Unusual Items
--
--
--
-110.7276
--
--
1/31/2020 - 9/1/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RDTCF Rapid Dose Therapeutics Corp.
0.0029
-80.79%
 
MYNDF MYND Life Sciences Inc.
0.0249
+17.45%
 
SYGGF Synairgen plc
0.0751
+13.76%
 
PXXLF Poxel S.A.
0.7000
+28.44%
 
AWKNF Awakn Life Sciences Corp.
0.1042
0.00%
 
MDXXF Pharmala Biotech Holdings Inc.
0.0850
-7.61%
 
NMLSF Nova Mentis Life Science Corp.
0.0081
-19.00%
 
NMTRQ 9 Meters Biopharma, Inc.
0.0000
0.00%
 
BRAXF Braxia Scientific Corp.
0.0050
0.00%
 
INFIQ Infinity Pharmaceuticals, Inc.
0.0000
0.00%